DK149599C - Fremgangsmaade til fremstilling af aminosukkerderivater kaldet trestatina, trestatin b og trestatin c eller salte deraf - Google Patents

Fremgangsmaade til fremstilling af aminosukkerderivater kaldet trestatina, trestatin b og trestatin c eller salte deraf

Info

Publication number
DK149599C
DK149599C DK61179A DK61179A DK149599C DK 149599 C DK149599 C DK 149599C DK 61179 A DK61179 A DK 61179A DK 61179 A DK61179 A DK 61179A DK 149599 C DK149599 C DK 149599C
Authority
DK
Denmark
Prior art keywords
trestatin
trestatina
salts
procedure
preparation
Prior art date
Application number
DK61179A
Other languages
Danish (da)
English (en)
Other versions
DK61179A (da
DK149599B (da
Inventor
Yasuji Suhara
Kiyoshi Ogawa
Kazuteru Yokose
Kimihiro Watanabe
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK61179A publication Critical patent/DK61179A/da
Publication of DK149599B publication Critical patent/DK149599B/da
Application granted granted Critical
Publication of DK149599C publication Critical patent/DK149599C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/99Enzyme inactivation by chemical treatment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK61179A 1978-02-14 1979-02-13 Fremgangsmaade til fremstilling af aminosukkerderivater kaldet trestatina, trestatin b og trestatin c eller salte deraf DK149599C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB583478 1978-02-14
GB583478 1978-02-14

Publications (3)

Publication Number Publication Date
DK61179A DK61179A (da) 1979-08-15
DK149599B DK149599B (da) 1986-08-04
DK149599C true DK149599C (da) 1987-06-01

Family

ID=9803510

Family Applications (1)

Application Number Title Priority Date Filing Date
DK61179A DK149599C (da) 1978-02-14 1979-02-13 Fremgangsmaade til fremstilling af aminosukkerderivater kaldet trestatina, trestatin b og trestatin c eller salte deraf

Country Status (26)

Country Link
US (1) US4273765A (OSRAM)
EP (1) EP0003616B1 (OSRAM)
JP (1) JPS54163511A (OSRAM)
AR (1) AR219150A1 (OSRAM)
AT (1) AT367451B (OSRAM)
AU (1) AU527318B2 (OSRAM)
CA (1) CA1121290A (OSRAM)
DE (2) DE2962165D1 (OSRAM)
DK (1) DK149599C (OSRAM)
ES (1) ES477653A1 (OSRAM)
FI (1) FI63062C (OSRAM)
FR (1) FR2416901A1 (OSRAM)
GR (1) GR72817B (OSRAM)
HU (1) HU181442B (OSRAM)
IE (1) IE47916B1 (OSRAM)
IL (1) IL56626A0 (OSRAM)
LU (1) LU80906A1 (OSRAM)
MC (1) MC1253A1 (OSRAM)
NL (1) NL7901182A (OSRAM)
NO (1) NO153011C (OSRAM)
NZ (1) NZ189625A (OSRAM)
PH (1) PH15084A (OSRAM)
PT (1) PT69218A (OSRAM)
SE (1) SE7901276L (OSRAM)
YU (1) YU41437B (OSRAM)
ZA (1) ZA79528B (OSRAM)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3166093D1 (en) * 1981-01-05 1984-10-18 Takeda Chemical Industries Ltd N-substituted pseudo-aminosugars, their production and use
JPS57146713A (en) * 1981-03-09 1982-09-10 Akira Endo Hypoglycemic
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same
US4678812A (en) * 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4762857A (en) * 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4885361A (en) * 1987-07-31 1989-12-05 Hoffmann-La Roche Inc. Sulfated oligosaccharides
JPH06503418A (ja) * 1990-11-30 1994-04-14 モノクロネティックス インターナショナル、インコーポレーテッド 慢性下位脊椎痛および頚部痛の診断法
CA2128044C (en) * 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
US7022684B2 (en) * 2000-05-24 2006-04-04 Pfizer Inc. Treatment of rumen acidosis with α-amylase inhibitors
EP1157696B1 (en) * 2000-05-24 2006-10-25 Pfizer Limited Treatment of rumen acidosis with alpha-amylase inhibitors
EP1689383B1 (en) 2003-11-19 2012-10-31 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
KR20070084455A (ko) * 2004-11-23 2007-08-24 워너-램버트 캄파니 엘엘씨 지질혈증 치료용 hmg co-a 환원효소 억제제로서의7-(2h-피라졸-3-일)-3,5-디히드록시-헵탄산 유도체
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
EP2094643B1 (en) 2006-12-01 2012-02-29 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2008261102B2 (en) 2007-06-04 2013-11-28 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
RU2010145944A (ru) * 2008-04-11 2012-05-20 Астеллас Фарма Инк. (Jp) Аминосахарное соединение и способ его получения
CA2930674A1 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2010093601A1 (en) 2009-02-10 2010-08-19 Metabasis Therapeutics, Inc. Novel sulfonic acid-containing thyromimetics, and methods for their use
JP2013528172A (ja) 2010-05-21 2013-07-08 ファイザー・インク 2−フェニルベンゾイルアミド
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2012120414A2 (en) 2011-03-04 2012-09-13 Pfizer Inc. Edn3-like peptides and uses thereof
US20150050371A1 (en) 2012-03-09 2015-02-19 Biotropics Malaysia Berhad Extract Formulations of Rhodamnia Cinerea And Uses Thereof
HK1220611A1 (zh) 2013-03-15 2017-05-12 Bausch Health Ireland Limited 用於治疗胃肠道病症的组成物
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
KR101695582B1 (ko) 2013-04-17 2017-01-13 화이자 인코포레이티드 심혈관 질환을 치료하기 위한 n-피페리딘-3-일벤즈아미드 유도체
SI3004138T1 (sl) 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
JP6769963B2 (ja) 2014-08-29 2020-10-14 ティエエッセ ファルマ ソチエタ レスポンサビリタ リミタータ α−アミノ−β−カルボキシムコン酸セミアルデヒド脱炭酸酵素の阻害剤
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JP2020500838A (ja) 2016-10-14 2020-01-16 ティエエッセ ファルマ ソチエタ レスポンサビリタ リミタータ Α−アミノ−β−カルボキシムコン酸セミアルデヒドデカルボキシラーゼの阻害剤
MX2021005904A (es) 2018-11-20 2021-09-08 Tes Pharma S R L Inhibidores de la ácido alfa-amino-beta-carboximucónico semialdehído descarboxilasa.
CN119060040A (zh) 2019-01-18 2024-12-03 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2064092C2 (de) * 1970-12-28 1983-06-01 Bayer Ag, 5090 Leverkusen Inhibitoren für Glykosidhydrolasen aus Actinomyceten
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
DE2347782C3 (de) * 1973-09-22 1979-10-11 Bayer Ag, 5090 Leverkusen Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
USRE29903E (en) 1975-03-19 1979-02-06 American Cyanamid Company Antibacterial antibiotics AM31α, AM31β and AM31γ
DE2614393C3 (de) * 1976-04-02 1980-04-03 Bayer Ag, 5090 Leverkusen Aminozucker-Derivate und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
PT69218A (en) 1979-03-01
AU4402879A (en) 1979-08-23
FI790486A7 (fi) 1979-08-15
IE790274L (en) 1979-08-14
HU181442B (en) 1983-07-28
LU80906A1 (de) 1980-09-24
AT367451B (de) 1982-07-12
DK61179A (da) 1979-08-15
ES477653A1 (es) 1980-03-01
FR2416901A1 (fr) 1979-09-07
DE2905649A1 (de) 1979-08-16
YU41437B (en) 1987-06-30
JPS54163511A (en) 1979-12-26
PH15084A (en) 1982-07-02
US4273765A (en) 1981-06-16
ATA108879A (de) 1981-11-15
NZ189625A (en) 1981-05-01
SE7901276L (sv) 1979-08-15
FR2416901B1 (OSRAM) 1980-10-24
NL7901182A (nl) 1979-08-16
DE2962165D1 (en) 1982-03-25
ZA79528B (en) 1980-02-27
AR219150A1 (es) 1980-07-31
AU527318B2 (en) 1983-02-24
NO153011B (no) 1985-09-23
NO153011C (no) 1986-01-02
EP0003616B1 (de) 1982-02-24
CA1121290A (en) 1982-04-06
MC1253A1 (fr) 1980-01-14
FI63062C (fi) 1983-04-11
FI63062B (fi) 1982-12-31
JPS643877B2 (OSRAM) 1989-01-23
DK149599B (da) 1986-08-04
EP0003616A3 (en) 1979-09-05
GR72817B (OSRAM) 1983-12-06
IL56626A0 (en) 1979-05-31
IE47916B1 (en) 1984-07-25
YU34879A (en) 1983-01-21
EP0003616A2 (de) 1979-08-22
NO790469L (no) 1979-08-15

Similar Documents

Publication Publication Date Title
DK149599C (da) Fremgangsmaade til fremstilling af aminosukkerderivater kaldet trestatina, trestatin b og trestatin c eller salte deraf
DK149895C (da) Fremgangsmaade til fremstilling af alfa-aminoacylprolyl-ng-carboxy-argininaldehydderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK178379A (da) Fremgangsmaade til fremstilling af n-substituerede moranolinderivater eller syreadditionssalte deraf
DK513480A (da) N-adamantansubstituerede tetrapeptidamider eller farmakologisk acceptable salte deraf og fremgangsmaade til deres fremstilling
DK15279A (da) Fremgangsmaade til fremstilling af tetrahydropyridinylindolderivater eller additionssalte deraf
DK503080A (da) Fremgangsmaade til fremstilling af imdazolderivater eller salte deraf
DK5976A (da) Fremgangsmade til fremstilling af biphenyloxyderivater eller salte heraf
DK473182A (da) Fremgangsmaade til fremstilling af 3-aminopregn-5-enderivater eller salte deraf
DK76578A (da) Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf
DK445078A (da) Fremgangsmaade til fremstilling af 4,5-dihydro-2-alkoxycarbonylamino-5-carbocyklisk arylimidazoler og derivater deraf
DK27078A (da) Fremgangsmaade til fremstilling af imidazoquinoliner eller salte deraf
DK11480A (da) Fremgangsmaade til fremstilling af anthracyclinderivater og syreadditionssalte deraf
DK324979A (da) Fremgangsmaade til fremstilling af imidazoquinoxaliner eller salte deraf
DK154650C (da) Analogifremgangsmaade til fremstilling af sukkerderivater
DK511878A (da) Fremgangsmaade til fremstilling af imidazobenzoazepiner eller salte deraf
DK75878A (da) Fremgangsmaade til fremstilling af 20,21,-di-noreburnameninderivater eller additionssalte deraf
DK232777A (da) Fremgangsmade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK58677A (da) Fremgangsmade til fremstilling af m-trifluormethylphenylpiperidinderivater eller additionssalte deraf
DK508776A (da) Fremgangsmade til fremstilling af derivater af daunorubicin eller syreadditionssalte deraf
DK338376A (da) Fremgangsmade til fremstilling af aminobenzocycloheptenderivater eller additionssalte deraf
DK146540C (da) Fremgangsmaade til fremstilling af alkaloider af leurosin-typen, eller syreadditionssalte deraf
DK57778A (da) Fremgangsmaade til fremstilling af 1,3-disubstitueret urinstof eller 2-thioruinstof
DK157021C (da) Analogifremgangsmaade til fremstilling af 2,3-polymethylen-4-oxo-4h-pyrido- eller -azepinooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf
DK224381A (da) Fremgangsmaade til fremstilling af benzazolderivater eller salte deraf
DK511978A (da) Fremgangsmaade til fremstilling af 5h-benzocyclohepten-7-aminderivater eller additionssalte deraf